
The BLING III trial investigated continuous vs intermittent β-lactam antibiotic infusions in critically ill patients with sepsis, finding no significant difference in 90-day mortality but suggesting potential benefits in clinical cure rates.

The BLING III trial investigated continuous vs intermittent β-lactam antibiotic infusions in critically ill patients with sepsis, finding no significant difference in 90-day mortality but suggesting potential benefits in clinical cure rates.

One of the most important drivers of a patients’ uncontrolled hypertension is medication nonadherence.

Increased levels of absolute lymphocyte count are associated with improved response to BCMA-targeted CAR T-cell therapy.

Study finds traces of “epigenetic scars” on the immune cells of patients who recovered from chronic hepatitis C infection.

The new approach could optimize precision medicine and lead to better outcomes across a variety of disease states.

The molecule can be a potential treatment that counters effects of early-life antibiotics, which can impact the gut microbiota and increase the risk of childhood atopy and asthma.

Unbridled drugflation, or a point-in-time measure of the rising cost of pharmacy benefits, is taking its toll on corporate bottom lines and household budgets.

The FDA’s designation builds off positive results in a phase 1b/2a clinical trial, showing that the vaccine can effectively target the Tau protein.

The investigational drug achieved non-inferiority compared to routine Factor VIII.

Pharmacologic approaches can increase the use of injectables.

Understanding preventive care reduces the risk of illnesses and decreases future costs.

Despite the century-long period of virus evolution, 6 of the 11 primates that received a cytomegalovirus-expressed flu vaccine survived the exposure to H5N1 flu.

The Lancet published data from DELTA 1 and DELTA 2 trials that displayed treatment success among individuals treated with delgocitinib cream.

Because T1D is not necessarily caused by genetics, educating patients about the signs and helping them get tested early is crucial.

Patients without insurance may not be able to afford the biosimilar adalimumab-adbm, even if it is available at a more affordable price than its reference product.

Career ladders for pharmacy technicians not only support the staff themselves, but also the broader success of the health system.

Adherence and efficacy were both higher in patients with HIV who took twice-yearly lenacapavir compared to those on oral preexposure prophylaxis medication.

Despite Muslim patients’ need for halal medication, more than 80% of pharmacists were found to lack knowledge about where to look to find alternative medications that are halal.

New strategies can improve cholesterol management in patients with ASCVD.

Pharmacists could play a major role in answering patient questions and providing counseling about cannabis

Tune into this episode of “Public Health Matters” to hear how Walmart is leveraging its network to provide HIV care and specialty pharmacy services and how integrating community pharmacy outreach is significant for patients.

AIC100 could meet an unmet medical need to effectively treat individuals with anaplastic thyroid cancer — the most aggressive form of the disease.

In April 2017, the drug was approved to treat the slow loss of the ability to walk for symptomatic patients aged 3 and older who had Batten disease.

Studies show an increased prevalence of autism spectrum disorder in children of mothers; mouse models have shown links between maternal asthma and altered behavior and brain function.

The decision offers patients with difficulty swallowing their medication expanded options for treatment administration.

Emerging treatments, collaboration between health care providers, and new policy proposals have led to a positive outlook for the future of nonalcoholic steatohepatitis (NASH) and its treatment.

It is essential for clinicians to properly diagnose patients with suspected AVWS and provide them proper treatment, which could be intravenous immunoglobulin.

Pharmacy personnel can be integrated to optimize antimicrobial use.

The decision expands the use of incobotulinumtoxinA beyond treatment of frown lines.